Skip to main content

Pharma News

Crack GPAT — Prepare for GPAT Online 

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Scientists discover how to reactivate cancer’s molecular “kill switch”

    Alternative RNA splicing is like a movie editor cutting and rearranging scenes from the same footage to create different versions of a film. By selecting which scenes to keep and which to leave out, the editor can produce a drama, a comedy, or even a thriller—all from the same raw material. Similarly, cells splice RNA in different ways to produce a variety of proteins from a single gene, fine-tuning their function based on need. However, when cancer rewrites the script, this process goes awry, fueling tumor growth and survival.
  • Meningococcal Vaccine Found to be Safe and Effective for Infants in Sub-Saharan Africa
    University of Maryland School of Medicine researchers helped conduct an important new global health study that found a vaccine that protects against five strains of meningitis prevalent in sub-Saharan Africa is safe and effective for use in young children beginning at 9 months of age.
  • Lighting the Way : How Activated Gold Reveals Drug Movement in the Body
    Tracking targeted drug delivery is often a challenge due to limitations in the current imaging techniques. A recent study by Tokyos Waseda University, reports a breakthrough imaging technique that allows direct and highly sensitive tracking of gold nanoparticles inside the body.
  • Targeted Alpha Therapy : A Breakthrough in Treating Refractory Skin Cancer
    Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of the body. It is one of the most aggressive forms of skin cancer, with current therapies—including immunotherapy and targeted drugs—showing limited effectiveness.
  • Alkem Laboratories launches generic empagliflozin
    Alkem Laboratories Ltd launches of generic empagliflozin and its combinations in India under the brand name Empanorm
  • New CAR-T Cell Therapy Shows Promise for Hard-to-Treat Cancers
    Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the cells, particularly against cancer cells that are harder for prior CAR-T therapies to detect and fight.
  • UT Health San Antonio develops drug found to more than double survival time for glioblastoma patients

    A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to extend survival for patients with glioblastoma, the most common primary brain tumor in adults.

  • CDSCO approved Durvalumab, cancer treatment of AstraZeneca
    AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation, Directorate General of Health Services, Government of India to import for sale and distribution of Durvalumab solution for infusion 120 mg/2.4 ml and 500 mg/10 ml (Imfinzi) for an additional indication.
  • Sun Pharma to acquire Checkpoint Therapeutics

    Sun Pharmaceutical Industries Limited and Checkpoint Therapeutics, Inc.  announced that they have entered into an agreement by which Sun Pharma will acquire Checkpoint, an immunotherapy and targeted oncology company.

  • New antibodies show potential to neutralize virus that causes COVID-19

    A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep pace with evolving viruses.

Subscribe to Pharma News